IL32213A - Substituted guanidines - Google Patents
Substituted guanidinesInfo
- Publication number
- IL32213A IL32213A IL32213A IL3221369A IL32213A IL 32213 A IL32213 A IL 32213A IL 32213 A IL32213 A IL 32213A IL 3221369 A IL3221369 A IL 3221369A IL 32213 A IL32213 A IL 32213A
- Authority
- IL
- Israel
- Prior art keywords
- guanidine
- bis
- compound
- hydrochloride
- ethanol
- Prior art date
Links
- 150000002357 guanidines Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 13
- 241001465754 Metazoa Species 0.000 claims description 10
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 208000003495 Coccidiosis Diseases 0.000 claims description 5
- 206010023076 Isosporiasis Diseases 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 208000010362 Protozoan Infections Diseases 0.000 claims 1
- 125000001589 carboacyl group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 71
- 239000000243 solution Substances 0.000 description 28
- 238000002360 preparation method Methods 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 18
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 17
- -1 1,3-bis ( -cyanobenzylideneamino)guanidine nitrate Chemical compound 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 11
- 229960004198 guanidine Drugs 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 241000287828 Gallus gallus Species 0.000 description 8
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- BVGPZRCQJJMXBI-UHFFFAOYSA-N 1,2-diaminoguanidine;nitric acid Chemical compound O[N+]([O-])=O.NN\C(N)=N/N BVGPZRCQJJMXBI-UHFFFAOYSA-N 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 239000012458 free base Substances 0.000 description 5
- NDEMNVPZDAFUKN-UHFFFAOYSA-N guanidine;nitric acid Chemical compound NC(N)=N.O[N+]([O-])=O.O[N+]([O-])=O NDEMNVPZDAFUKN-UHFFFAOYSA-N 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229940050176 methyl chloride Drugs 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- SCIZLHIMZCLSND-UHFFFAOYSA-N diamino(carbamimidoyl)azanium;chloride Chemical compound Cl.NN(N)C(N)=N SCIZLHIMZCLSND-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 150000007857 hydrazones Chemical class 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000003250 oocyst Anatomy 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LTWIBTYLSRDGHP-UHFFFAOYSA-N 1,2-bis[(4-chlorophenyl)methylideneamino]guanidine;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C=NNC(=N)NN=CC1=CC=C(Cl)C=C1 LTWIBTYLSRDGHP-UHFFFAOYSA-N 0.000 description 2
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 2
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 241000223924 Eimeria Species 0.000 description 2
- 241000223932 Eimeria tenella Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000021017 Weight Gain Diseases 0.000 description 2
- ADSXHTNGGZYNKA-UHFFFAOYSA-N [(e)-[amino(methylsulfanyl)methylidene]amino]azanium;chloride Chemical compound Cl.CSC(=N)NN ADSXHTNGGZYNKA-UHFFFAOYSA-N 0.000 description 2
- 230000001165 anti-coccidial effect Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- VQNVZLDDLJBKNS-UHFFFAOYSA-N carbamimidoylazanium;bromide Chemical compound Br.NC(N)=N VQNVZLDDLJBKNS-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000003224 coccidiostatic agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- XIWZUMMBBRRJGP-UHFFFAOYSA-N ethyl n'-aminocarbamimidothioate;hydroiodide Chemical compound I.CCSC(=N)NN XIWZUMMBBRRJGP-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- WQUPOMUBXOPGSN-UHFFFAOYSA-N methyl n'-aminocarbamimidothioate Chemical compound CSC(N)=NN WQUPOMUBXOPGSN-UHFFFAOYSA-N 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OQXROOQXEFQTPM-UHFFFAOYSA-N propyl n'-aminocarbamimidothioate;hydrobromide Chemical compound Br.CCCSC(=N)NN OQXROOQXEFQTPM-UHFFFAOYSA-N 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- LJABNWZBAGZTEQ-UHFFFAOYSA-N 1,2-bis[(4-bromophenyl)methylideneamino]guanidine;nitric acid Chemical compound O[N+]([O-])=O.C=1C=C(Br)C=CC=1C=NN=C(N)NN=CC1=CC=C(Br)C=C1 LJABNWZBAGZTEQ-UHFFFAOYSA-N 0.000 description 1
- CGDZXOHAXDLFIW-UHFFFAOYSA-N 1,2-diamino-1-methylguanidine;hydrobromide Chemical compound Br.CN(N)C(=N)NN CGDZXOHAXDLFIW-UHFFFAOYSA-N 0.000 description 1
- HAZRIBSLCUYMQP-UHFFFAOYSA-N 1,2-diaminoguanidine;hydron;chloride Chemical compound Cl.NN\C(N)=N/N HAZRIBSLCUYMQP-UHFFFAOYSA-N 0.000 description 1
- BUZYGTVTZYSBCU-UHFFFAOYSA-N 1-(4-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C=C1 BUZYGTVTZYSBCU-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical class CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UYZKWRHTYCCDMP-UHFFFAOYSA-N 2-[(4-chlorophenyl)methylideneamino]guanidine Chemical compound NC(N)=NN=CC1=CC=C(Cl)C=C1 UYZKWRHTYCCDMP-UHFFFAOYSA-N 0.000 description 1
- PZOZWNDIDLORJG-UHFFFAOYSA-N 2-amino-1-[(4-chlorophenyl)methylideneamino]guanidine Chemical compound NNC(=N)NN=CC1=CC=C(Cl)C=C1 PZOZWNDIDLORJG-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical group FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- NIEBHDXUIJSHSL-UHFFFAOYSA-N 4-iodobenzaldehyde Chemical group IC1=CC=C(C=O)C=C1 NIEBHDXUIJSHSL-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000026803 Animal Parasitic disease Diseases 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- FVIGODVHAVLZOO-UHFFFAOYSA-N Dixanthogen Chemical compound CCOC(=S)SSC(=S)OCC FVIGODVHAVLZOO-UHFFFAOYSA-N 0.000 description 1
- 241000223931 Eimeria acervulina Species 0.000 description 1
- 241000499566 Eimeria brunetti Species 0.000 description 1
- 241000223934 Eimeria maxima Species 0.000 description 1
- 241000530449 Eimeria mivati Species 0.000 description 1
- 241000499563 Eimeria necatrix Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010037075 Protozoal infections Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 206010047897 Weight gain poor Diseases 0.000 description 1
- FABQYDLGFZXBIK-VZUCSPMQSA-N [(e)-(4-chlorophenyl)methylideneamino]thiourea Chemical compound NC(=S)N\N=C\C1=CC=C(Cl)C=C1 FABQYDLGFZXBIK-VZUCSPMQSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940124536 anticoccidial agent Drugs 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- XKLVLDXNZDIDKQ-UHFFFAOYSA-N butylhydrazine Chemical compound CCCCNN XKLVLDXNZDIDKQ-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- UUDRLGYROXTISK-UHFFFAOYSA-N carbamimidoylazanium;iodide Chemical compound I.NC(N)=N UUDRLGYROXTISK-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical class COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- JIMBSYFWVPLTMK-UHFFFAOYSA-N ethyl n'-[(4-cyanophenyl)methylideneamino]carbamimidothioate;hydroiodide Chemical compound I.CCSC(=N)NN=CC1=CC=C(C#N)C=C1 JIMBSYFWVPLTMK-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical class CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940080839 methionine 500 mg Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
NOVEL SUBSTITUTED GUANIDINES 32213/3 ; The new compositions of the present invention contain as the active component compounds of the following formula: wherein R. and R_ are selected from the group consisting of halogen, trifluoromethyi, and cyano, and RQ are selected from the group consisting of hydrogen and halogen, g, R^, ?; and R^ are selected from the group con* ing of hydrogen and lower alkyl, and Rg is selected from the group consisting of hydrogen and lower allssinoyl. and the pharmacologically acceptable acid salts thereof.
^Bhere the subetituents ?; g and RQ indicate hydrogen, the application relies on the date of July 1st, 1968, and in all other cases the application relies on the date June 26th, 1969.
The acid salts can be, for example, nitrate, hydrochloride, hydrobromide, methooulfate, and. the like; The term loweralkyl is intended to include those having 1 to 4 carbon atoms and lower aJkanoyl, those having 1 to 4 carbons in addition to the carbonyl group. The term halogen includes chlorine, bromine, fluorine, and iodine.
The compounds of this invention are, in general, . crystalline solids, ranging in color from white to pale yellow, slightly soluble in water and lower alcohols and insoluble in benzene, toluene and chloroform.
The present invention also includes new bis(benzylldeneamino) guanidlnes of the formula: R 9 32213/2 wherein Rx, Ra, R6, Re, R7 and Rg are as. defined hereinbefore and pharmacologically acceptable acid salts thereof.
The. above active components and novel compounds can be prepared by reacting a compound of the formula: . ' . ! wherein Rx , Ra and Ra are as hereinabove described, . dissolved in a water miscible organic :solvent,. with an aqueous or aqueous alcoholic solution of a compound of the formula: (H3N-N-)2C=NH»HX . , ' R7 9 . wherein ^ is as hereinabove described and X is the anion of a pharmacologically acceptable acid. The mixture is heated "to * from 50° to the boiling point of the solvent and held there for from one to ten minutes and then cooled to room temperature.
The precipitated product is ' collected, washed with ethanol and/ or ether and dried. ' . '' Other methods of preparing the instant compounds are illustrated by the equation's which follow: e¬ where Rx, Ra, R3, and R^ are as hereinabove described and Z is chlorine or bromine.
Compounds in which R^ is loweralkanoyl are prepared by reaction of the compounds in which Ro, is H with the appropriate organic acid anhydride. mmi #JV in11 mi M mdii i i m imiwΜΙΦ/ΜΒΝΜI Hkkkhhi H I ljl hidMMUmW Among the active components and novel compounds within the scope of the present invention are the following: 1, 3-bis(k-chlorobenzylideneamino) guanidine nitrate , 1, 3-bis(4-chlorobenzylideneamino )guanidine hydrochloride, l,3-bis(4-chlorobenzylideneamino)guanidine methosulfate , 1, 3-bis (4-bromobenzylideneamino )guanidine nitrate, l,3-bis( -bromobenzylideneamino) uanidine hydro- chloride, l,3-bis(3>½-dichlorobenzylideneamino)guanidine nitrate, l,3-bis(>, -dichlorobenzylideneamino)guanidine hydrochloride, 1,3-bis ( -cyanobenzylideneamino)guanidine nitrate, l,3-bis(4-cyanobenzylideneamino)guanidine hydrochloride , 1, 3-bis ( -chloro-a-methylbenzylideneamino ) guanidine nitrate, l,3-bis(4-chloro-a-methylbenzylidene- amino)guanidine hydrochloride, l-( -bromobenzylidene- amino ) ->- (4-cyanobenzylideneamino ) guanidine hydrobromide, l-(4-bromobenzylideneamino)-3- ( -chlorobenzylideneamino)- guanidine hydrochloride .
The active components and novel compounds of the present invention are highly active antiprotozoal agents in warm-blooded animals. For example, these compounds have anticoccidial activity against Eimeria tenella as shown by the following test: The animals were Peterson cross cockerels, 7 days old and of approximately equal size and weight. These cockerels were divided into groups and the groups were placed in separate cages with wire floors. Medicated and control diets were then presented to the groups of birds 2 days before inoculation while they were still in uncontaminated quarters. During the entire period of the tests, the brids ate and drank ad libitum. Control groups were maintained on a standard unmedicated commercial type chicken diet. Test groups were maintained on the same standard diet in which a measured concentration of test compound had been incorporated homogeneously. The cockerels were inoculated once orally with sporulated oocysts of Eimeria tenella. The number of oocysts inoculated directly into the crops of all cockerels in the tests was sufficient to produce high mortality in the untreated controls. The quantity necessary to produce high mortality, was determined prior to the times of inoculation by giving graded quantities of oocysts to comparable birds. Seven days following inosulation the tests were terminated and the mortality rate was recorded for each group. The results of these tests appear in Table I and show conclusively that these compounds are highly effective as anticoccidial agents. The tests represent very severe laboratory challenges, and lower concentrations than those shown would be effective under practical field conditions.
TABLE I TABLE I - Continued The compounds of the present invention have high activity against other coccidial species in chickens. Thus, l,l-bis( -chlorobenzylidene amino )guanidine completely protected treated chickens from mortality due to Eimeria necatrix, and from poor weight gains due to E. acervulina, E. brunetti , E. maxima or E. mivati .
Methods used were essentially identical with those previously cited with appropriate modifications. Weight gains were determined 7 days after single experimental inoculations with the designated species of coccidia.
The results are summarized in Table II.
TABL&II Anticoccidial Activity of 1,¾?-Bis( 4-chlorobenzylideneamino) - guanidine Eimeria ppm in No. % % control spp . Diet Survival Weight gain Salt necatrix 0 19 21 31 metho- sulfate 15 20 100 80 20 100 103 acervulina 0 20 100 57 nitrate 45 20 100 99 brunetti 0 20 100 76 hydrochloride 15 20 100 100 20 100 95 maxima 0 20 100 58 hydrochloride 20 100 101 20 100 95 45 20 100 100 mivati 0 20 95 52 hydrochloride 15 20 100 86 20 100 91 20 100 100 φ It is anticipated that the compounds of this invention will prove widely useful in a variety of vehicles, modes or means of administration or dispersal for the purpose of minimizing, preventing, controlling, treating, ameliorating or curing protozoal infections with sensitive organisms. One of these infections is coccidiosis which is a protozoan parasitic disease widespread in animals, causing a greater economic loss among domestic and game animals in temperate climates than any other protozoan disease. Coccidiosis is the most important animal parasitic disease of chickens, the causative agents being protozoa of the genus Eimeria, and is also important in other domestic animals such as turkeys, sheep, cattle and pigs.
The present compositions and novel compounds are active in warm-blooded animals as anti-malarial agents. When tested in mice in the range of from 150 mg./kg. to 0 mg./kg. they show an activity comparable to quinine.
Although administration of the compounds for coccidiosis will generally be most practical in or with the feed, or in the drinking water, the compounds may also be administered to individual hosts in the form of tablets, drenches, capsules, or the like, or by in-jection. These latter methods of administration are, of course, less practical for treatment of large groups of animals than they are for treating limited numbers of animals, but they are quite practical for use on a small scale or on an individual basis.
With the compounds of the instant invention, medicated feeds are usually prepared by thoroughly admixing about 0.0005 to 0.05$ by weight and preferably about 0.0015 to 0.025 by weight of active compound with a nutritionally balanced animal feed, as for example, the chick feed described in the examples hereinafter.
Where it is desirable to prepare a concentrate or premix for ultimate dilution in feed to the above levels, generally about 1$ to 2 $ and preferably about 3$ to 10$ by weight of medicament is blended with an edible organic or inorganic carrier, e.g., corn meal or corn and soybean meal, or alfalfa, or mineral salts containing a small amount of an edible dusting oil such as, for example, corn oil, or soybean oil. The thus prepared premix may then be added to the complete animal poultry feed prior to administration.
EXAMPLE 1 Preparation of l,3-Bis( -chlorobenzylideneamino)guanidine nitrate, hydrochloride and methosulfate A boiling solution of 14.1 grams of 4-chloro-benzaldehyde (slight excess) in 250 milliliters of ethanol is stirred vigorously as a solution of 6.1 grams of 1,3-diaminoguanidine nitrate and 0.5 milliliters of concentrated nitric acid in 50 milliliters of water is added in one portion. The reaction mixture is stirred as the temperature recedes to room temperature. The reaction mixture is then allowed to stand for several hours. The precipitate which forms is collected, washed with hot ethanol, air-dried and finally dried at 60°C. under reduced pressure. The yield is 14.0 grams of product and the melting point is 198°C. with decomposition.
The hydrochloride or methosulfate salt may be prepared by this same procedure, substituting equivalent amounts of the appropriate guanidine salt and employing 0.5 milliliters of the appropriate acid. . The hydrochloride salt melts at 289-290o(J. with decomposition. The methosulfate salt melts at 217-224°C. with decomposition.
EXAMPLE 2 Preparation of l,3-Bis(4-chlorobenzylideneamlno)guanidine The free base of the title compound is prepared by suspending 8 g. of the nitrate salt (Example 1) in 200 ml. of anhydrous ethanol, adding 2.5 ml. of ION sodium hydroxide solution, stirring and heating until the reaction mixture becomes homogeneous, and finally cooling the solution and filtering the resultant solid. The melting point of the free base is l87-l88°C.
EXAMPLE 3 Preparation of 1,3-ΒΤΠ 4-bromobenzylideneamino)guanidine A boiling solution of 20.0 grams of 4-bromo-benzaldehyde in 250 milliliters of ethanol is stirred 3 vigorously as a solution of 6.1 grams of 1,^-diamino-guanidine nitrate and 0.5 milliliters of concentrated nitric acid in 50 milliliters of water is added in one portion. The reaction mixture is stirred as the temperature recedes to room temperature. The reaction mixture is allowed to stand for several hours. The precipitate which forms is collected, washed with hot ethanol, air dried and finally dried at 60°C. under reduced pressure. The yield is 16.5 grams of product and the melting point is 178°-l80°C. with decomposition.
EXAMPLE k Preparation of l, 3-Bis( 3,4-dichlorobenzylideneamino)- guanidine Nitrate A boiling solution of 17 .6 grams of 3, 4-dichlorobenzaldehyde in 250 milliliters of ethanol is stirred vigorously as a solution of 6 .1 grams of 1, 3-diaminoguanidine nitrate and 0.5 milliliters of concentrated nitric acid in 50 milliliters of water is added in one portion. The reaction mixture is stirred as the temperature recedes to room temperature. The reaction mixture is then allowed to stand for several hours.
The precipitate which forms is collected, washed with hot ethanol, air dried and finally dried at 60°C. under reduced pressure. The yield is 17.5 grams of product and the melting point is 195-196°C. with decomposition.
EXAMPLE 5 Preparation of l, 3-Bis( 4-cyanobenzylideneamino) guanidine A boiling solution of 1 .1 grams of 4-cyano-benzaldehyde in 250 milliters of ethanol is stirred vigorously as a solution of 6 .1 grams of 1 , 3-diamino-guanidine nitrate and 0.5 milliliters of concentrated nitric acid in 50 milliliters of water is added in one portion. The reaction mixture is stirred as the temperature recedes to room temperature. The reaction mixture is then allowed to stand for several hours. The precipitate which forms is collected, was ed with hot ethanol, air dried and finally dried at 60°C. under reduced pressure. The yield is 15 .1 grams of product and the melting point is 205 °-210°C. with decomposition.
EXAMPLE 6 Preparation of l, 3-Bis( -chloro-a-methylbenzylideneamino)- guanidine Nitrate A boiling solution of 15 . grams of 4-chloro-acetophenone in 250 milliliters of ethanol is stirred vigorously as a solution of 6 .1 grams of 1, 3-diamino-guanidine nitrate and 0.5 milliliters of concentrated nitric acid in 50 milliliters of water is added in one portion. The reaction mixture is stirred as the temperature recedes to room temperature. The reaction mixture is then allowed to stand for several hours. The precipitate which forms is collected, washed with hot ethanol, air dried and finally dried at 60°C. under reduced pressure. The yield is 8.7 grams of product and the melting point is 215°C. with decomposition.
EXAMPLE 7 Preparation of l, -Bis( 4-iodobenzylideneamino)guanidine Hydrochloride Following the procedure of Example 1 and substituting 4-iodobenzaldehyde for -chlorobenzaldehyde and 1, 2-diaminoguanidine hydrochloride for 1 , 5-diamino-guanidine nitrate the product of the example is obtained. The hydrochloride has a melting point of 288 ° -291°C, dec.
EXAMPLE 8 Preparation of 1, 5-Bis( -fluorobenzylideneamino)guanidine Nitrate Using the procedure of Example 1 and substituting 4-fluorobenzaldehyde for 4-chlorobenzaldehyde the product of the example is obtained. The nitrate has a melting point of 169° -170°C. , dec.
EXAMPLE 9 Preparation of Methyl thiocarbazimidate hydrochloride Excess methyl chloride is collected in a dry ice-acetone-cooled trap and added to a tared pressure vessel containing 91.1 g. of powdered thiosemicarbazide in 600 ml. of anhydrous ethanol. Weighing the vessel plus contents shows that 53 g. of methyl chloride has been added. The reaction mixture is magnetically stirred while heating in an oil bath temperature of 77 to 110°C. for 48 minutes. After 33 minutes, the reaction has become homogeneous. It is cooled in ice and the resultant rose-white solid filtered and dried in a vacuum oven. The yield of the title compound is 121 g. melting point 154-15 °C.
Substitution of dimethyl sulfate, ethyl iodide or propyl bromide for methyl chloride and allowing the reactions to proceed in refluxing anhydrous ethanol instead of under pressure, results in the pre-paration of methyl thiocarbazimidate methosulfate, ethyl thiocarbazimidate hydroiodide, and propyl thiocarbazimidate hydrobromide, respectively.
EXAMPLE 10 Preparation of MethyT 3-(4-cCTorobenzylidene)thiocarbazimi- date hydrochloride A solution of -8 g. of 4-chlorobenzaldehyde in 10 ml. of warm absolute ethanol is added all at once to a stirred solution of 5 g. of methyl thiocarbazimidate hydrochloride in 100 ml. of warm absolute alcohol. The reaction mixture is stirred at room temperature for about 15 minutes and cooled in ice. The white solid product is filtered off and air dried; melting point 212-2l4°C.
The following are prepared in like manner: methyl 3- (4-bromobenzylidene) thiocarbazimidate metho-sulfate from 4-chlorobenzaldehyde and methyl thiocar- bazimidate methosul ate, ethyl 3- (4-cyanobenzylidene)-thlocarbazimidate hydroiodide from 4-cyanobenzaldehyde and ethyl thiocarbazimidate hydroiodide, and propyl 3-( 3 , 4-dichloroberizylidene )thiocarbazimidate hydrobromide from , 4-dichlorobenzaldehyde and propyl thiocarbazimidate hydrobromide.
EXAMPLE 11 Preparation of MethyT~3-( -chIorobenzylidene)thiocarbazlmi- date hydrochloride A 10% molar excess of methyl chloride is added to 2.14 g. of 4-chlorobenzaldehyde thiosemicarbazone and 25 ml. of anhydrous ethanol in a pressure vessel.
The reaction mixture is magnetically stirred and heated in an oil bath for 1 1/2 hour. The crystalline title compound separates on cooling and is filtered off and air dried.
EXAMPLE 12 Preparation of l, 3-BTs(4-chlorobenzylideneamlno)guanidine : hydrochloride A solution of 101 g. of 4-chlorobenzaldehyde in 40 ml. of warm 9 ethanol is added portionwise to a stirred solution of diaminoguanidine hydrochloride in 4 0 ml. of 90$ ethanol at 70°C. Addition of the first portion causes rapid boiling and the reaction mixture is cooled to a little above room temperature before the remainder of the 4-chlorobenzaldehyde solution is added.
Stirring is continued for 15 minutes and the reaction mixture is cooled in ice, filtered, and air dried. The yield is 122 g. of solid, melting point 295°C. with decomposition.
The same product is obtained when l-amino-3-( 4-chlorobenzylideneamino)guanidine hydrochloride (Example 13) is allowed to react under similar conditions as above with an equimolar amount of 4-chlorobenzalde-hyde .
The same product is also obtained from the reaction of methyl 3-(4-chlorobenzylidene)thiocarbazimi-date (Example 10) with the hydrazone of 4-chlorobenzalde-hyde in refluxing 95$ ethanol . The hydrazone of 4-chlorobenzaldehyde is prepared according to the procedure for the synthesis of hydrazones of aromatic alde-hydes and ketones outlined in G. Newkome and D. Fishel, J. Org. Chem., 51, 677 (1966).
EXAMPLE I? Preparation of l-Amino"-5-(4-chlorobenzylideneamino) - guanidine hydrochloride To a solution of 2.6 g. of methyl 3- -chloro-benzylidene )thiocarbazimide in 10 ml. of boiling absolute ethanol is added 0.6 g. of hydrazine hydrate. The reaction mixture is cooled in ice and the solid 1-amino-3-(4-chlorobenzylideneamino)guanidine removed by filtration.
Similarly the reaction of methyl 3-(4-bromo-benzylidene )thiocarbazimidate methosulfate, ethyl 3-(4-cyanobenzylidene) thiocarbazimidate hydroiodide, and propyl 3·"·(3, -dichlorobenzylidene ) thiocarbazimidate hydrobromide with hydrazine yield, respectively, 1-amino-3-(4-bromobenzylideneamino)guanidine methosulfate, l-amino-3-(4-cyanobenzylideneamino)guanidine hydroiodide, and l-amino-3-(3,4-dichlorobenzylideneamino)guanidine hydrobromide .
The reaction of 4-chlorobenzaldehyde with a 4-fold molar excess of diaminoguanidine hydrochloride in boiling 90" ethanol also gives l-amino-3-(4-chlorobenzyl-ideneamino )guanidine hydrochloride, together with a small amount of 1, 3-bis(4-chlorobenzylideneamino) guanidine hydrochloride .
EXAMPLE 14 Preparation of l-(4-Bromobenzylideneamino)-3-(4-chloro- benzylldeneamino ) guanidine hydrochloride A solution of 1.85 g. of 4-bromobenzaldehyde in 10 ml. of ethanol is added to a solution of 2.48 g. of l-amino-3-(4-chlorobenzylideneamino)guanidine hydrochloride in 25 ml. of boiling 9 $ ethanol. The reaction mixture is cooled and the solid product removed by filtration and air dried.
In a similar manner the reaction of 1-amino- 3- (4-bromobenzylideneamino) guanidine methosulfate with 4-chlorobenzaldehyde gives the methosulfate salt of the subject compound. The reaction of l-amino-3- (4-cyano-benzylideneamino) uanidine hydroiodide with 4-chlorobenzaldehyde gives l-(4-chlorobenzylideneamino)-3-(4-cyanobenzylideneamino)guanidlne hydroiodide. The reaction of l-amino-3-( 3, 4-dichlorobenzylideneamino) guanidine hydrobromide and p_-chlorobenzaldehyde gives l-(4-chloro-benzylideneamino ) -3- (>,4-dichlorobenzylideneamino ) -guanidine hydrobromide .
EXAMPLE 15 Preparation of Chick Diet The following specific feed composition is an example of poultry feed as a carrier for the coccidiostats described hereinbefore.
Vitamin-Amino acid 0 .5$ Trace Minerals 0.1$ Sodium Chloride 0.3$ Dicalcium Phosphate 1.2$ Ground Limestone 0.5$ Stabilized Fat 4$ Dehydrated Alfalfa, 17$ protein 2$ Corn Gluten Meal, 41$ protein 5$ Menhaden Fish Meal, 60 protein 5$ Soybean Oil Meal, 44$ protein 30$ Ground Yellow Corn, Fine To 100$ The vitamin pre-mix in the above feed compo-sition is prepared from the following formulation. The expressions of quantity relate to units per kil gram of the feed composition.
Bytylated Hydroxy toluene 125 mg. di-Methionine 500 mg.
Vitamin A 3300 I.U.
Vitamin D3 1100 I.C.U.
Riboflavin 4 .4 mg.
Vitamin E 2 .2 I.U.
Niacin 27.5 mg.
Pantothenic Acid 8.8 mg.
Choline Chloride 500 mg.
Folic Acid 1 .43 mg.
Mendadione Sodium Bisulfate 1 .1 mg.
Vitamin Βχ2 11 meg.
Ground Yellow corn, Fine To 5 gm.
EXAMPLE 16 Preparation of l, 3-Bis(4-trlfluoromethylbenzylldeneamlno)- guanidlne hydrochloride A solution of 10 g. of -trifluoromethylbenzal-dehyde in the minimum amount of 95$ ethanol is added to a boiling solution of 3.6 g. of diaminoguanidine hydrochloride in 50 ml. of 95$ ethanol and a few ml. of water. The solution is stirred and allowed to cool and the solid removed by filtration and washed with 95$ ethanol and ether. The yield is 9.6 g. of white solid with. a melting point of 272-273 -5$ with decomposition.
A mixture of 1^« 1 grams of li-chlorobenzaldehyde, I..6 grams of methylhydrazine and 500 ml. of dried benzene is stirred at reflux in a continuous water removal apparatus until no further separation of water is noted. The benzene solution of the resultant methylhydrazone of ij.-chlqrobenzaldehyde is cooled to room temperature and treated with a solution of 5· 3 grams of cyanogen bromide in 100 ml. of benzene. The reaction .mixture is stirred at reflux for four hours, a white precipitate separating out during this time. The precipitate is filtered from the hot solution, washed and dried. It is recrystallized from ethanol of i;-chloi¾benzalx iyde and one molar equivalent of l,.3-f¾snlno-l , 3-dime thylguanidine hydTObranide are raf Ιηχβ in ethasol solution in 1he presents of a little kQ aqueous hydrobromi*c acid for a few minutes.
EXAMPLE 18 Preparation of l,3-Bis(t-chTorobenzylideneamino)-l, 3-di-n- butylguan ine hydrobromide The preparation of the above compound is carried out by the procedure of Example 17, an equivalent of n-butylhydrazine replacing the methylhydrazine . The isolated product after re-crystallization from ethanol-diethyl ether decomposes about 150°C.
EXAMPLE 19 Preparation of 1, 3-Bis (li-Chlorobenzylideneamino ) -l-methylguani- dine hydrobromide The preparation of -the title compound is carried out essentially by the procedure of Example 1, 7· 3 grams of 1,3-diamino-l-methylguanidine hydrobromide replacing the 1,3-di-aminoguanidine nitrate and 0.-5 ml* of &$ HBr being employed as catalyst. The yield of product is 1 .1. grams and the ■ ύ point is 276-278°C.
EXAMPLE 20 Preparation of 2-Acetyl-l , 3-bi3( -chlorobenzylideneaminoguani- dine A mixture of 20 g. of 1, 3-bis(p_-chlorobenzylideneamino ) guanidine free base and 9 ml. of acetic anhydride in 300 ml. of anhydrous ether is stirred at reflux for 16 hours 9 then filtered to give a solid containing starting material, and acetylated material. The solid is reacted with an additional 3 ml* of acetic anhyd ide in 300 ml. of toluene for 1 hour, cooled to room temperatu e end filtered. The solid (II4. g. ) is dissolved in 100 ml. of chloroform and treated with 50 ml. of 3 N hydrochloric acid, and the resulting solid is filtered, the crude product is slurried in 100 ml. of boiling chloroform, filtered, and dried - ■ form and aqueous sodium bicarbonate, and the chloroform layer is dried and evaporated to give 2-acetyl-l, 3-bis (lj.-chlorobenzyl-ideneamino)guanidine, melting, point 197-200°C. (dec . ) .
The reaction of 1, 3-bis (p_-chlbrobenzylideneamino )-guanidine free base with acetyl chloride in ether gives the same acetyl derivative according to thin layer chromatograph c evidence, along with recovered starting material.
When 1,3-bis (p_-chlorobenzylideneamino )-l,3-dimethyl-guanidine free base ia submitted to the above reaction conditions with acetic anhydride, ; there is obtained the corresponding 2-acetyl-l, 3-bis (i.-chlorobenzylideneamino)-l, 3-dimethylguani-dine .
Similarly, the reaction of 1 , 3-bis ( -cyanobenzylidene-amino)guanidine and propionic anhydride in refluxing ether gives 1, 3-bis (l+-cyanobenzylideneamino )-2-propionyl )guanidine.
Claims (5)
1. 7. 68 ' . 26. 6. 69 1. A composition for the control of coccidiosis infections in poultr comprising an edible . carrier and about between 0.0005 and 0.65 by weight of a compound of the formula: wherein R x and R_. are selected from the group consisting of halogen, trifluorome thyl and .cyano, Rs ' and Re are selected from the group consisting of hydrogen and halogen, R3, R4, Ry and Rg are selected from the group consisting of hydrogen and lower alkyl, is selected from the group consisting of hydrogen and lower alkanoyl and the pharmaceutically acceptable acid .salts thereof.
2. A composition according to Claim 1, wherein said compound is administered in an edible carrier containing about between 0.0015% and 0.025% by weight of said compound.
3. A composition according to Claim 2, wherein said compound is 1, 3-bis(l+-chlorobenzylideneamino )guanidine hydrochloride. 1. 7. 68 i . A method of controlling coccidiosis and other 26. 6. 69 * protozoan infections in warm-blooded animals comprising administering orally or parenterally to said hosts a protozoacidally effective amount of a compound of the formula: ?9 ; ·
4. R3 R4
5. ' ■ ■ 'S32&3/2 . : . »
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74124768A | 1968-07-01 | 1968-07-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL32213A0 IL32213A0 (en) | 1969-07-30 |
| IL32213A true IL32213A (en) | 1972-12-29 |
Family
ID=24979938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL32213A IL32213A (en) | 1968-07-01 | 1969-05-12 | Substituted guanidines |
Country Status (21)
| Country | Link |
|---|---|
| JP (2) | JPS5324411B1 (en) |
| AT (1) | AT297015B (en) |
| BE (1) | BE735375A (en) |
| BR (1) | BR6910272D0 (en) |
| CA (1) | CA927394A (en) |
| CH (1) | CH562209A5 (en) |
| CS (1) | CS170139B2 (en) |
| DE (1) | DE1933112C3 (en) |
| DK (1) | DK129448B (en) |
| ES (1) | ES368955A1 (en) |
| FR (1) | FR2012054B1 (en) |
| GB (1) | GB1256723A (en) |
| IE (1) | IE33371B1 (en) |
| IL (1) | IL32213A (en) |
| IT (1) | IT1000009B (en) |
| MY (1) | MY7400237A (en) |
| NL (1) | NL143559B (en) |
| PH (1) | PH9607A (en) |
| PL (2) | PL89014B1 (en) |
| SE (1) | SE370396B (en) |
| YU (3) | YU33388B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624214A (en) * | 1970-03-25 | 1971-11-30 | Dow Chemical Co | Guanidene derivatives for coccidiosis |
| ZA708675B (en) * | 1970-12-28 | 1971-10-27 | American Cyanamid Co | Compositions of substituted guanidines and method of use thereof |
| US3992446A (en) | 1973-07-27 | 1976-11-16 | American Cyanamid Company | Substituted aminochlorobenzylamino guanidine compounds |
| WO2000040549A1 (en) * | 1999-01-06 | 2000-07-13 | Lonza Ag | Method for producing robenidine or derivatives thereof |
| HK1042078B (en) | 1999-01-06 | 2004-01-30 | Lonza Ag | Method for producing robenidine or derivatives thereof |
| CN105579432A (en) * | 2013-05-01 | 2016-05-11 | 尼奥酷里私人有限公司 | Compounds and methods for treating infections |
| AU2015311598A1 (en) | 2014-09-02 | 2017-03-16 | Neoculi Pty Ltd | Methods for treating protozoan infections |
| CN116133654A (en) * | 2020-04-24 | 2023-05-16 | 纽库利私人有限公司 | Methods and compositions for treating fungal infections |
-
1969
- 1969-05-07 CA CA050850A patent/CA927394A/en not_active Expired
- 1969-05-12 IL IL32213A patent/IL32213A/en unknown
- 1969-06-19 SE SE6908793A patent/SE370396B/xx unknown
- 1969-06-19 IE IE641/69A patent/IE33371B1/en unknown
- 1969-06-23 GB GB1256723D patent/GB1256723A/en not_active Expired
- 1969-06-25 NL NL696909722A patent/NL143559B/en not_active IP Right Cessation
- 1969-06-27 BR BR210272/69A patent/BR6910272D0/en unknown
- 1969-06-28 IT IT38304/69A patent/IT1000009B/en active
- 1969-06-30 BE BE735375D patent/BE735375A/xx not_active IP Right Cessation
- 1969-06-30 ES ES368955A patent/ES368955A1/en not_active Expired
- 1969-06-30 CS CS4622A patent/CS170139B2/cs unknown
- 1969-06-30 DK DK354469AA patent/DK129448B/en not_active IP Right Cessation
- 1969-06-30 PH PH10492*UA patent/PH9607A/en unknown
- 1969-06-30 FR FR696921970A patent/FR2012054B1/fr not_active Expired
- 1969-06-30 DE DE1933112A patent/DE1933112C3/en not_active Expired
- 1969-06-30 YU YU01672/69A patent/YU33388B/en unknown
- 1969-07-01 PL PL1969156043A patent/PL89014B1/pl unknown
- 1969-07-01 AT AT629869A patent/AT297015B/en not_active IP Right Cessation
- 1969-07-01 PL PL1969157956A patent/PL89704B1/pl unknown
- 1969-07-01 CH CH1006769A patent/CH562209A5/xx not_active IP Right Cessation
-
1972
- 1972-05-24 JP JP5156072A patent/JPS5324411B1/ja active Pending
- 1972-05-24 JP JP5156172A patent/JPS5324412B1/ja active Pending
-
1974
- 1974-08-15 YU YU2235/74A patent/YU33445B/en unknown
- 1974-08-15 YU YU2234/74A patent/YU33444B/en unknown
- 1974-12-30 MY MY237/74A patent/MY7400237A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1256723A (en) | 1971-12-15 |
| PL89014B1 (en) | 1976-10-30 |
| MY7400237A (en) | 1974-12-31 |
| PH9607A (en) | 1976-01-19 |
| ES368955A1 (en) | 1971-07-16 |
| IE33371L (en) | 1970-01-01 |
| DE1933112C3 (en) | 1975-05-15 |
| IE33371B1 (en) | 1974-06-12 |
| CA927394A (en) | 1973-05-29 |
| DE1933112A1 (en) | 1970-01-08 |
| NL6909722A (en) | 1970-01-05 |
| CH562209A5 (en) | 1975-05-30 |
| DE1933112B2 (en) | 1974-09-26 |
| CS170139B2 (en) | 1976-08-27 |
| DK129448C (en) | 1975-03-03 |
| AT297015B (en) | 1972-03-10 |
| YU223574A (en) | 1976-08-31 |
| YU33444B (en) | 1977-02-28 |
| YU33388B (en) | 1976-12-31 |
| BE735375A (en) | 1969-12-30 |
| NL143559B (en) | 1974-10-15 |
| DK129448B (en) | 1974-10-14 |
| IL32213A0 (en) | 1969-07-30 |
| FR2012054A1 (en) | 1970-03-13 |
| YU167269A (en) | 1976-06-30 |
| YU33445B (en) | 1977-02-28 |
| FR2012054B1 (en) | 1973-01-12 |
| SE370396B (en) | 1974-10-14 |
| JPS5324411B1 (en) | 1978-07-20 |
| PL89704B1 (en) | 1976-12-31 |
| JPS5324412B1 (en) | 1978-07-20 |
| IT1000009B (en) | 1976-03-30 |
| BR6910272D0 (en) | 1973-02-08 |
| YU223474A (en) | 1976-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6053024B2 (en) | Method for producing 1-(4-phenoxy-phenyl)-1,3,5-triazine derivative | |
| US3228833A (en) | Anticoccidial compositions and methods of using same | |
| US3992446A (en) | Substituted aminochlorobenzylamino guanidine compounds | |
| US3941825A (en) | Substituted aminobenzylideneamino guanidine compounds | |
| IL32213A (en) | Substituted guanidines | |
| US3769432A (en) | Compositions and method of use of substituted guanidines | |
| US3493572A (en) | Process for producing quinoxaline-di-n-oxides | |
| JPS6136516B2 (en) | ||
| US3901944A (en) | 1,3-bis(substituted benzylideneamino)guanidines | |
| CA1250576A (en) | Quinazolin-4-one-3-acetonyl hydrazone and their use against coccidiosis | |
| US4151298A (en) | Anthelmintic compositions | |
| US4112120A (en) | Methods and compositions for use in animal husbandry | |
| US4311710A (en) | Anticoccidial formulation and method | |
| US3816530A (en) | Novel chemical compounds and processes for preparing same | |
| GB1561624A (en) | Sulphonylhydrazones of 1,4-dioxo- and 4-osoquinoxaline-2carboxaldehvde | |
| US3415838A (en) | Nitrogen-containing derivatives of 2,5-dichloro-3-nitrobenzoic acid | |
| US4153723A (en) | Anthelmintic agents | |
| US4073791A (en) | 1-Substitutedphenyl-4(1H)-pyridinone hydrazones | |
| US4015016A (en) | [(2-Alkoxyberzylidine)amino]quanidines and their anticoccidal use | |
| JPS6135985B2 (en) | ||
| US3075877A (en) | Anticoccidial compositions comprising 5-nitro-2-furaldehyde cyanoacetyl or dichloroacetyl-hydrazone | |
| RU2032670C1 (en) | S-(1-methylpiridinium-3-methyl)-n,n'-dimethylthiouronium diiodide showing radioprotector activity | |
| US3773943A (en) | Alpha,alpha,alpha-trifluoro-6-substituted-5-nitro-m-toluic acid,5'-nitrofurylidene hydrazide compounds as growth promotants | |
| US3856975A (en) | Anticoccidial composition containing guanidine derivatives | |
| US3957997A (en) | Anticoccidial complexes of 4,4'-dinitrocarbanilides |